<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="262">
  <stage>Registered</stage>
  <submitdate>24/08/2005</submitdate>
  <approvaldate>25/08/2005</approvaldate>
  <actrnumber>ACTRN12605000215628</actrnumber>
  <trial_identification>
    <studytitle>Early rehabilitation in patients with hypercapnic respiratory failure.</studytitle>
    <scientifictitle>The effect of early exercise rehabilitation on exercise capacity and dyspnoea in patients with hypercapnic respiratory failure</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Not applicable</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Hypercapnic respiratory failure</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Other respiratory disorders / diseases</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Physical Medicine / Rehabilitation</conditioncode1>
      <conditioncode2>Other physical medicine / rehabilitation</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The study will be conducted over a 6-8 day period during a hospital admission for hypercapnic respiratory failure. On day 1, baseline anthropometric data, measurement of exercise capacity, quality of life, an arterial blood gas, spirometry and maximum inspiratory and expiratory muscle pressures at the mouth were collected. Day 2 subjects were randomised to either a control or early exercise rehabilitation with supplemental oxygen or early exercise rehabilitation group (with non-invasive ventilation and supplemental oxygen). All groups receive standard medical care, including non-invasive ventilation at rest as required. Early rehabilitation consists of a supervised, progressive exercise program of approximately 20-30 minutes each day for at least 4 days. Day 6-8 baseline measures repeated.</interventions>
    <comparator>Control group does not receive any exercise rehabilitation during the trial.</comparator>
    <control>Active</control>
    <interventioncode>None</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Exercise capacity - measured by the 6MWT and an unsupported arm endurance test</outcome>
      <timepoint>Comparisons made within group pre and post intervention, and between groups pre and post intervention, and in proportion of change from pre-post intervention</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Dyspnoea - using Borg dysponea scale (0-10)</outcome>
      <timepoint>Comparisons made within group pre and post intervention, and between groups pre and post intervention, and in proportion of change from pre-post intervention</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>SpO2% - using pulse oximeter</outcome>
      <timepoint>Measured continuously throughout exercise</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Rate of perceived exertion - using Borg RPE scale (0-10)</outcome>
      <timepoint>Measured each minute during exercise tests</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Quality of life - using St Georges Respiratory Questionnaire (SGRQ) and the Maugeri Foundation Respiratory Failure Questionnaire (MRF-28)</outcome>
      <timepoint>Measured pre and post training and at three month review</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Daytime PaCO2 greater than 45mmHg, pH greater than 7.34, 3 out of 4 of : increase in FiO2 required to maintain SpO2 greater than 90% compared to baseline, increase in dyspnoea in the past week, increase in cough/sputum past week, decrease in subjective exercise tolerance over past week.</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>Not stated</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>pH equal to or less than 7.34, gross hypoxaemia, unstable angina or myocardial infarct in previous month, uncontrolled hypertension, febrile, resting tachycardia, orthopaedic or neurological conditions that limit exercise capacity, decreased level of conciousness, major psychiatric illness.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>sealed numbered opaque envelopes</concealment>
    <sequence>random number generation on a computer, (stratified block randomisation)</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>12/05/2005</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>60</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Terminated</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Royal Prince Alfred Hospital, Woolcock Institute of Medical Research, University of Sydney</primarysponsorname>
    <primarysponsoraddress>Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Missenden Rd, Camperdown NSW 2050, Australia</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>Australian Postgraduate Award (APA) NSW Government 2004-2007</fundingname>
      <fundingaddress>Scholarships Office, Level 5, Jane Foss Russell Building, G02, The University of Sydney NSW 2006, Australia</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>Ian Collier Memorial Scholarship (NSW Physiotherapy Registration Board) 2004</fundingname>
      <fundingaddress>NSW Physiotherapy Registration Board, PO Box K599, Haymarket NSW 2000, Australia</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Physiotherapy Research Foundation (Australian Physiotherapy Association) 2004</fundingname>
      <fundingaddress>Australian Physiotherapy Association, PO Box 437, Hawthorn BC VIC 3122, Australia</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>George Burniston Cumberland Foundation Fellowship 2005</fundingname>
      <fundingaddress>George Burniston Cumberland Foundation, Faculty of Health Sciences, Cumberland Campus C42, The University of Sydney, PO Box 170, Lidcombe NSW 1825, Australia</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>nil</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Royal Prince Alfred Hospital (Sydney South West Area Health Service) University of Sydney</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Ms Collette Menadue</name>
      <address>Sleep Unit
Royal Prince Alfred Hospital
Level 11 E Block
Missenden Road
Camperdown NSW 2050</address>
      <phone>+61 2 95158708</phone>
      <fax>+61 2 95157691</fax>
      <email>collette@med.usyd.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Ms Wendy Taylor</name>
      <address>PO Box M77
Missenden Road
Camperdown NSW 2050</address>
      <phone>+61 2 95156578</phone>
      <fax>+61 2 95505865</fax>
      <email>volunteers@woolcock.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>